[1] | GUNASEKERA S P,GUNASEKERA M,LONGLEY R E,etal.Discodermolide:a new,marine-derived immunosup-pressive compoundI.In vitro studies[J]..Transplantation.1991,52(4):650-656 | [2] | LONGLEY R E,CADDIGAN D,HARMODY D,et al.Discodermolide:a new,marine-derived immunosuppressivecompound��.In vivo studies[J]..Transplantation.1991,52(4):656-661 | [3] | CUNNINGHAM S L,CUNNINGHAM A R,DAY B W,etal.CoMFA,HQSAR and molecular docking studies ofbutitaxel analogues with-t��ubulin[J].J Mol Model.2005,11(1):48-54 | [4] | JORDAN M A.Mechanism of action of antitumor drugs thatinteract with microtubules and tubulin[J].Curr Med ChemAnti-Canc Agents,2002,(2):1-17. | [5] | KLEIN L E,FREEZE B S,SMITH��A B,et al.Themicrotubule stabilizing agent discodermolide is a potentinducer of accelerated cell senescence[J].Cell Cycle.2005,4(3):501-507 | [6] | LITMAN T,DRULEY T E,STEIN W D,et al.From MDRto MXR:new understanding of multidrug resistancesystems,their properties and clinical significance[J].CellMol Life Sci.2001,58(7):931-959 | [7] | ORR G A,PINARD P V,MCDAID H,et al.Mechanisms ofTaxol resistance related to microtubules[J].Oncogene,2003,22(47):7 280-7 295. | [8] | BUEY R M,BARASOAIN I,JACKSON E,et al.Microtubule interactions with chemically diverse stabilizingagents:Thermodynamics of binding to the paclitaxel sitepredicts cytotoxicity[J].Chemistry&Biology.2005,12(12):1- | [9] | MARTELLO L A,MCDAID H M,REGL D L,et al.Taxoland discodermolide represent a synergistic drug combinationin human carcinoma cell lines[J].Clin Cancer Res,2000,6(5):1 978-1 987. | [10] | HONORE S,KAMATH K,BRAGUER D,et al.Synergisticsuppression of microtubule dynamics by discodermolide andpaclitaxel in non-small cell lung carcinoma cells[J].Cancer Res,2004,64(14):4 957-4 964. | [11] | HUANG G S,BARCONS L L,FREEZE B S,et al.Potentiation of taxol efficacy by discodermolide in ovariancarcinoma xenograft-bearing mice[J].Clin Cancer Res.2006,12(1):298-304 | [12] | SMITHIII A B,FREEZE B S,LAMARCHE M J,et al.Discodermolide analogues as the chemical component ofcombination bacteriolytic therapy[J].Bioorganic&Medicinal Chemistry Letters.2005,15(15):3- | [13] | PATERSON I,FLORENCE G J.The development of apractical total synthesis of discodermolide,a promisingmicrotubule-stabilizing anticancer agent[J].Eur J OrgChem,2003,12:2 193-2 208. | [14] | GUNASEKERA S P,PAUL G K.Five new discodermolideanalogues from the marine sponge discodermia species[J].J Nat Prod.2002,65(11):1- | [15] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Large-scale synthesis of the anti-cancer marine naturalproduct(+)-discodermolidePart 1:Synthetic strategyand preparation of a common precursor[J]..OrganicProcess Research&Development.2004,8(1):92-100 | [16] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Large-scale synthesis of the anti-cancer marine naturalproduct(+)-discodermolidePart 2:Synthesis offragments C1-6 and C9-14[J]..Organic Process Research&Development.2004,8(1):101-106 | [17] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Large-scale synthesis of the anti-cancer marine naturalproduct(+)-discodermolidePart 3:Synthesis of fragmentC15-21[J]..Organic Process Research&Development.2004,8(1):107-112 | [18] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Large-scale synthesis of the anti-cancer marine naturalproduct(+)-discodermolidePart 4:Preparation offragment C7-24[J]..Organic Process Research&Development.2004,8(1):113-121 | [19] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Large-scale synthesis of the anti-cancer marine naturalproduct(+)-discodermolidePart 5:Linkage of fragmentsC1-6 and C7-24 and finale[J]..Organic Process Research&Development.2004,8(1):122-130 | [20] | MICKEL S J,SEDELMEIER G H,NIEDERER D,et al.Astudy of the paterson boron aldol reaction as used in thelarge-scale total synthesis of the anticancer marine naturalproduct(+)-discodermolide[J].Organic ProcessResearch&Development.2005,9(1):113-120 | [21] | LEE A Y,HAGIHARA M,SCHREIBER S L,et al.Atomicstructure of the trypsin-cyclotheonamide a complex.Lessonsfor the design of serine protease inhibitors[J].J Am ChemSoc,1993,115(26):12 619-12 622. | [22] | JACK T,COLLINS J L,SCHREIBER S L.Synthesis ofnatural and modified trapoxins,useful reagents for exploringhistone deacetylase function[J].J Am Chem Soc.1996,118(43):10- | [23] | SMITHIII A B,BEAUCHAMP T J,LAMARCHE M J,et al.Evolution of a gram-scale synthesis of(+)-discodermolide[J].J Am Chem Soc.2000,122(36):8- | [24] | SMITHIII A B,FREEZE B S,BROUARD I,et al.Apractical improvement,enhancing the large-scale synthesisof(+)-discodermolide:A third-generation approach[J].Org Lett,2003,5(23):4 405-4 408. | [25] | SMITHIII A B,FREEZE B S,MING X,et al.Totalsynthesis of(+)-discodermolide:A highly convergentfourth-generation approach[J].Org Lett.2005,7(9):1- | [26] | HARRIED S S,LEE C P,YANG G,et al.Total synthesis ofthe potent microtubule-stabilizing agent(+)-discodermolide[J].J Org Chem,2003,68(17):6 646-6 660. | [27] | MARSHALL J A,JOHNS B A.Synthesis of discodermolidesubunits by SE2 addition of nonracemic allenylstannanes toaldehydes[J].J Org Chem.1998,63(3):817-823 | [28] | PATERSON I,FLORENCE G J,GERLACH K,et al.Totalsynthesis of the antimicrotubule agent(+)-discodermolideusing boron-mediated aldol reactions of chiral ketones[J].Angew Chem Int Ed.2000,39(2):377-380 | [29] | PATERSON I,FLORENCE G J,GERLACH K,et al.Apractical synthesis of(+)-discodermolide and analogues:Fragment union by complex aldol reactions[J].J Am ChemSoc,2001,123(39):9 535-9 544. | [30] | PATERSON I,FLORENCE G J,GERLACH K,et al.1,6-asymmetric induction in boron-mediated aldol reactions:Application to a practical total synthesis of(+)-discodermolide[J].Org Lett.2003,5(1):35-38 | [31] | PATERSON I,DELGADO O,FLORENCE G J,et al.Asecond-generation total synthesis of(+)-discodermolide:The development of a practical route using solely substrate-based stereocontrol[J].J Org Chem.2005,70(1):150-160 | [32] | PATERSON I,LYOTHIER I.Development of a third-generation total synthesis of(+)-discodermolide:Anexpedient still-gennari-type fragment coupling utilizing anadvanced-��ketophosphonate[J].J Org Chem,2005,70(14):5 494-5 507. | [33] | BALLONE P,MARCHI M.A density functional study of anew family of anticancer drugs:Paclitaxel,taxotere,epothilone,and discodermolide[J].J Phys Chem A,1999,16(103):3 097-3 102. | [34] | MARTELLO L A,LAMARCHE M J,He L,et al.Therelationship between Taxol and(+)-discodermolide:synthetic analogs and modeling studies[J].Chemistry&Biology.2001,8(9):843-855 | [35] | HE L,JAGTAP P G,KINGSTON D G I,et al.A commonpharmacophore for Taxol and the epothilones based on thebiological activity of a taxane molecule lacking a C-13 sidechain[J].Biochemistry,2000,39(14):3 972-3 978. | [36] | RAO S,HE L,CHAKRAVARTY S,et al.Characterizationof the taxol binding site on the microtubule.Identification ofArg(282)in-Ltubulin as the site of photoincorporation of a7-benzophenone analogue of Taxol[J].J Biol Chem,1999,274(53):37 990-37 994. | [37] | XIA S,KENESKY C S,RUCKER P V,et al.A photoaffinityanalogue of discodermolide specifically labels a peptide in-t��ubulin[J].Biochemistry.2006,45(39):11- | [38] | KAR S,FLORENCE G,PATERSON I,et al.Discodermolide interferes with the binding of tau protein tomicrotubules[J].FEBS Lett.2003,539(1/3):34-36 | [39] | SANCHEZ P V M,KUBICEK K,MEILER J,et al.Thetubulin-bound conformation of discodermolide derived byNMR studies in solution supports a common pharmacophoremodel for epothilone and discodermolide[J].Angew ChemInt Ed.2006,45(44):7- |
|